Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour

Nat Commun. 2014 Jun 9:5:4039. doi: 10.1038/ncomms5039.

Abstract

Wilms tumour (WT) is an embryonal kidney neoplasia for which very few driver genes have been identified. Here we identify DROSHA mutations in 12% of WT samples (26/222) using whole-exome sequencing and targeted sequencing of 10 microRNA (miRNA)-processing genes. A recurrent mutation (E1147K) affecting a metal-binding residue of the RNase IIIb domain is detected in 81% of the DROSHA-mutated tumours. In addition, we identify non-recurrent mutations in other genes of this pathway (DGCR8, DICER1, XPO5 and TARBP2). By assessing the miRNA expression pattern of the DROSHA-E1147K-mutated tumours and cell lines expressing this mutation, we determine that this variant leads to a predominant downregulation of a subset of miRNAs. We confirm that the downregulation occurs exclusively in mature miRNAs and not in primary miRNA transcripts, suggesting that the DROSHA E1147K mutation affects processing of primary miRNAs. Our data underscore the pivotal role of the miRNA biogenesis pathway in WT tumorigenesis, particularly the major miRNA-processing gene DROSHA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Humans
  • MicroRNAs / genetics*
  • Molecular Sequence Data
  • Mutation*
  • Ribonuclease III / chemistry
  • Ribonuclease III / genetics*
  • Sequence Homology, Amino Acid
  • Wilms Tumor / genetics*

Substances

  • MicroRNAs
  • DROSHA protein, human
  • Ribonuclease III